Literature DB >> 2891219

Necrotizing activity of tumor necrosis factor: histopathological investigation using Meth A sarcoma and granulation tissue.

T Kawai1, N Satomi, N Sato, A Sakurai, K Haranaka, T Goto, M Suzuki.   

Abstract

The action of tumor necrosis factor (TNF) was investigated histopathologically in mice using methylcholanthrene A (Meth A)-induced sarcomas and granulation tissue induced by autotransplantation of fragments of liver and spleen. Highly purified murine TNF caused hemorrhagic necrosis of both the tumors and the granulation tissue. Proliferation of tumor capillaries, demonstrated microangiographically, occurred 2 h after TNF administration and hyperemia of tumor vessels was obvious after 3-6 h. Hyperemia and capillary leakage were also observed in the granulation tissue 6 h after TNF injection and hemorrhage was noted in the epidermis after 12 h. These results strongly suggest that the in vivo necrotizing action of TNF is mainly related to capillary injury.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891219     DOI: 10.1007/bf02890263

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  4 in total

1.  Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization.

Authors:  P Barath; M C Fishbein; J Cao; J Berenson; R H Helfant; J S Forrester
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 2.  Hyperthermic modulation of macrophage-tumor cell interactions.

Authors:  S P Tomasovic; J Klostergaard
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

Review 3.  Unleashing endogenous TNF-alpha as a cancer immunotherapeutic.

Authors:  Steven F Josephs; Thomas E Ichim; Stephen M Prince; Santosh Kesari; Francesco M Marincola; Anton Rolando Escobedo; Amir Jafri
Journal:  J Transl Med       Date:  2018-08-31       Impact factor: 5.531

4.  Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.

Authors:  Patrycja Koszałka; Ewa Szmit; Andrzej Myśliwski; Jacek Bigda
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.